Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study

Gemma K. Reynolds, Mark R. Dowling, Safia Belbachir, Nilu Perera, Jian Li, Vinay Vanguru, Benjamin W. Teh, Mary Ann Anderson, Allison Barraclough, Constantine S. Tam, P. Joy Ho, Simon J. Harrison, Andrea S. Henden, Karin A. Thursky, Monica A. Slavin

Open source

DOI
10.1016/j.cmi.2026.06.019
Published
2026-06
Container
Clinical Microbiology and Infection
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2026.06.019,
  title = {Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study},
  author = {Gemma K. Reynolds and Mark R. Dowling and Safia Belbachir and Nilu Perera and Jian Li and Vinay Vanguru and Benjamin W. Teh and Mary Ann Anderson and Allison Barraclough and Constantine S. Tam and P. Joy Ho and Simon J. Harrison and Andrea S. Henden and Karin A. Thursky and Monica A. Slavin},
  year = {2026},
  journal = {Clinical Microbiology and Infection},
  doi = {10.1016/j.cmi.2026.06.019},
  url = {https://doi.org/10.1016/j.cmi.2026.06.019}
}

RIS

TY  - JOUR
TI  - Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study
AU  - Gemma K. Reynolds
AU  - Mark R. Dowling
AU  - Safia Belbachir
AU  - Nilu Perera
AU  - Jian Li
AU  - Vinay Vanguru
AU  - Benjamin W. Teh
AU  - Mary Ann Anderson
AU  - Allison Barraclough
AU  - Constantine S. Tam
AU  - P. Joy Ho
AU  - Simon J. Harrison
AU  - Andrea S. Henden
AU  - Karin A. Thursky
AU  - Monica A. Slavin
PY  - 2026
JO  - Clinical Microbiology and Infection
DO  - 10.1016/j.cmi.2026.06.019
UR  - https://doi.org/10.1016/j.cmi.2026.06.019
ER  - 

APA

Reynolds, G. K., Dowling, M. R., Belbachir, S., Perera, N., Li, J., Vanguru, V., Teh, B. W., Anderson, M. A., Barraclough, A., Tam, C. S., Ho, P. J., Harrison, S. J., Henden, A. S., Thursky, K. A., & Slavin, M. A. (2026). Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.06.019

Source records